Consultation: Removal of reconsideration process from requests for priority review and advance consideration for Notice of Compliance with conditions
Current status: Open
This consultation opened on December 22, 2025 and will close on February 20, 2026.
Health Canada is proposing that negative decisions arising from requests for Priority Review or Advance Consideration for Notice of Compliance with conditions (NOC/c) would no longer be subject to reconsideration requests.
Join in: How to participate
Health Canada has posted a notice outlining its proposal to no longer accept requests for reconsideration related to refusals to grant Priority Review status or advance consideration for NOC/c for forthcoming drug submissions. Health Canada is seeking to solicit feedback from stakeholders regarding this proposal.
Send us an email
Send an email to brdd-cppic_brdd-cppci@hc-sc.gc.ca with your ideas or comments to make yourself heard.
Who is the focus of this consultation
We will engage with:
- pharmaceutical and biopharmaceutical drug industries
- academics
- health system partners
- the public
Contact us
Centre for Policy, Pediatrics and International Collaboration
Biologic and Radiopharmaceutical Drugs Directorate
Health Products and Food Branch
Health Canada
Email: brdd-cppic_brdd-cppci@hc-sc.gc.ca